This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. tied) Crusoe Energy Systems , $500M, energy: This is not the first time Crusoe has made this list. billion valuation in the process. Founded in 2018, the company has raised $1.2
That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.
In fact, it took $200 million or more to make the list last month, as defense tech and cybersecurity led the way. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in 2025. Harvey develops AI tools that help legal pros with research, document review and contract analysis.
Sure, duediligence matters in the investment process, but lying about your capabilities can undercut the founder-investor relationship — and in extreme cases, to the detriment of the larger, global startup market. Soon she was the CEO of a company with a $10 billion valuation, but it turned out that the technology didn’t work.
When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. As AI pervades biotech, what are investors looking for in 2023?
Enterprise tech and AI Cerebras Systems : Yes, this one is kind of cheating. national security review on UAE-based G42 ‘s minority investment in the AI chipmaker. Gen Teare Health and biotech Hinge Health : This is another IPO prediction where were not exactly going out on a limb (pun intended in this case).
Venture money wasnt concentrated in just one sector, as VCs invested in everything from artificial intelligence to biotech to energy. The Norwalk, Connecticut-based firm did not disclose investor names, instead saying it came from a private investor whose portfolio focuses on global technology and real estate investments.
The hearing loss market has long been dominated by a handful of legacy players with little incentive to innovate due to outdated regulations and social stigma. On Monday, the FDA announced that hearing aids and other hearing technology can now be sold over the counter. But a new ruling from the U.S.
Now, certain industries are emerging as potential areas where New Zealand can win in the tech space. Deep tech, medtech/biotech, climate tech, and crypto and blockchain are all areas that investors say they’re either actively investing in or watching for signs of scale. New Zealanders make really good founders.
Speedoc , a health tech platform that brings hospital care to homes, has raised $28 million in pre-Series B funding. Patients are able to receive frequent medical reviews, 24/7 nursing, intravenous therapies, blood tests and in-person visits. ” ‘Move fast and break things’ is a bad idea for health tech startups.
Now tech companies across industries are poised for an even better year, according to more than a dozen investors we talked to in the country. Other investors felt that a broader range of industries, like fintech and biotech, would eventually produce the biggest companies in the country. Oh, and one more thing.
We featured generative AI companies five years before the popular investors took notice and climate tech 2.0 We’re seeing input/output startups that want to rewrite the rules of recycling and purification with new tech. It’s deep tech but actionable. Silver tech – Life expectancy is on the rise and the U.S.
The whole human proteome may be free to browse thanks to DeepMind , but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. At first Glyphic would be processing samples sent to them, but ultimately their tech could live in other labs as their competitors do now.
Due to its safer formula, Howler can be used as the last spray in the program, and its differentiator is a shorter re-entry period — farmers can spray in the morning and be able to go back out in the field in the afternoon. The company saw 10x sales growth in 2020, Uknes told TechCrunch.
5 investors discuss Boston’s resilient tech ecosystem Boston’s university-to-startup pipeline defies downturn to grow and diversify In order to build a startup culture, a city or region needs some key elements in place – like an innovation engine to drive startup ideas. It also has a long history of innovation and a rich tech legacy.
Once samples are scanned in the lab, they could be reviewed by hematologists working from anywhere. For instance, some papers argue, the manual review of samples doesn’t often add much to doctors’ diagnostic dataset. You can zoom around in one of the images here. Image Credits: Scopio.
The biggest was in New York-based mortgage servicing platform Valon Technologies ’ $100 million Series C led by WestCap. million Series C for San Francisco-based Infinitus Systems , which has developed an AI platform specifically built to automate manual healthcare phone calls. The largest round the company led was a $51.5
Like a museum, but on the blockchain : Despite his usual misgivings for crypto tech, we spot Haje covering a rare blockchain story, about Arkive, and its building of the world’s first decentralized museum. Resourceful Humans: On TechCrunch+, Kyle reports that investors remain bullish on HR tech as the Great Resignation slows.
“InstaDeep happened to be quite different from other companies in our pipeline as they were actually into deep tech versus applying technology to a certain sector, where basically, you become an operator in that sector. And it was also interesting, especially in Africa, where such companies are quite rare.
It speaks to the speed with which genetics has permeated our lives, but despite massive improvements to the technology, the process can still be a bit clunky in the lab. What I noticed was that the existing technologies for moving, mixing and heating fluids were archaic,” he said. “I And that sample has to get prepped the right way.
Research on psychedelics was stalled for decades due to DEA scheduling, but capabilities in the fields of pharmacology and medicinal chemistry advanced significantly during this “dark age.” Most ancillary services and technology will not take off until drugs commercialize, so we see few near-term opportunities in other verticals anyway.
When R-Zero was founded in April 2020, the company primarily focused on developing hospital-grade UVC disinfection systems, or lights that can neutralize certain types of viruses (more on this later). Amid pandemic, returning to offices remains an open question for tech leaders. million in funding at a $256.5 million valuation.
To change a system that’s reactionary instead of proactive is far from simple. Gina Bartasi launched Kindbody, her third fertility startup, in 2018, after her own journey helped her understand just how broken and antagonistic the system is. The company today has 12 outlets in 10 cities in the U.S.
At N2Growth, we approach the healthcare leadership market with a nuanced lens, drawing on decades of industry experience to ensure that leaders possess the necessary technical expertise and the resilience, strategic insight, and emotional intelligence essential for inspiring teams and shaping the future of patient care.
” No hard feelings — the tech was largely notional then, he admitted — but since that time the team has continued its work, raised some money , and what was a promising if not well supported thesis then has turned into one backed by firsthand data and clinical outcomes. But ultimately it’s still targeted physical therapy.
In 2020, Scottish startups collectively raised £345 million, according to Tech Nation, and with nearly 2,500 startups, it has the highest number of budding tech companies outside London. However, the city’s tech scene is apparently lackluster when it comes to legal tech, blockchain and consumer-facing technology.
The world’s labs are under pressure to do more tests and process more materials, not just due to COVID but from the growing biotech and drug development sectors — and automation is the sure path forwards. So building a system that’s designed to be deployed and adjusted by the on-site crew has been a major focus.
Biotech took center stage, notching three of the top four rounds. Obsidian Therapeutics , $161M, biotech: It was another big week for biotech startups raising huge sums of cash. The Los Angeles-based startup is a marketplace that offers video reviews. This week, Obsidian Therapeutics leads the way.
Serial Kenyan tech entrepreneur Mike Macharia has spent the last two decades helping enterprises like East Africa’s biggest telco Safaricom to create infrastructure that bolsters their growth. But I had never thought of building tech for us (the masses). CarePoint raises $10M to spread healthcare tech across Africa.
a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. This latest round is intended to formulate a massive investment in a “roadmap” for developing model organ systems created to fit drugmakers’ needs and bring the idea of an organ-on-a-chip into use in the lab. .
Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. As the technology exhausts its honeymoon period, and companies in all industries find new ways of using it to get ahead of the competition, a new race is on.
Conventional electronic media like flash drives and hard drives require energy consumption to process a vast amount of high-density data and information overload and are vulnerable to security issues due to the limited space for storage. There is also an expensive cost issue when it comes to transmitting the stored data.
I began to think about health problems, and honestly, dogs are a better system for using genetics to better their health than humans,” Boyko said. Another common genetic risk is HUU, or Hyperuricosuria, which is elevated levels of uric acid in urine that could lead to bladder stones due to the way dogs process minerals.
The idea for the startup came to him as he listened to cardiologist, and now co-founder, Patrick Gladding explain how time-consuming and potentially inaccurate it is for doctors to have to review multiple scans manually everyday. Having more tech talent on board will help HeartLab advance its product offering. ” said Hewitt.
This has led to a spike in people turning to the private medical sector, a trend some argue heralds the start of a two-tier healthcare system where those with financial means effectively pay to fast-track their treatment. ” Bullock said. for the time being.”
Between his roles as co-leader of Mayfield Fund’s engineering biology practice and founder at IndieBio, Arvind Gupta reviewed approximately 470 startup pitches last year. There’s a lot of optimism that technology can still create real solutions that can drive real value creation. The exit value is what drives it all.
“You could claim the system is broken. 5 investors explain why longevity tech is a long-term play. The decline was due to COVID-19, but reporter Anna Heim interviewed five investors who are backing startups developing technology that may allow us to live longer, healthier lives. In 2019, it was 78.86
The results showed that Infinidat continues to deliver the business value and technical value that large enterprises need and prioritize. Click here to read more Gartner Peer Insights reviews by users of the InfiniBox hybrid and InfiniBox SSA solutions for primary storage. stars out of 5 in the Primary Storage Arrays market.
Every branch of science is increasingly reliant on big data sets and analysis, which means a growing confusion of formats and platforms — more than inconvenient, this can hinder the process of peer review and replication of research. That means other researchers move on, build their own thing, and further reinforce the silo system.
You can find out right now why a slew of Global Fortune 500 enterprises deploy Infinidat enterprise storage solutions, including our award-winning InfiniBox™ SSA II all-flash system, InfiniBox® hybrid, and InfiniGuard®, supported by our unparalleled white glove service. You don’t only have to take our word for it.
Sure, there are some, including two $3 billion deals in Q2: Merck buying privately held biotech EyeBiotech for as much as $3 billion, and Hg buying AuditBoard for more than $3 billion. However, chipmakers also have caused a stir due to some of the big cash they’ve raised — or are about to raise. But there just haven’t been a lot.
With the Laboratory Information Management System, researchers can now link experiments to specific samples or files, as well as easily share information with other lab members and organizations involved. What is a Laboratory Information Management System (LIMS)? There are various LIMS solutions depending on the industry.
The technology gives districts visibility so they can optimize routes and even deliver real-time updates to parents. Yes, there’s a lot of AI Looking at the list above, it’s clear artificial intelligence is a popular core or enabling technology among new, female-founded unicorns. Its founders are Gina Bartasi and Joanne Schneider.
Sustainable technology: A competitive advantage for businesses Greg Bentham 03 Sept 2024 Facebook Twitter Linkedin The strategic imperative of sustainable technology In today’s fast-paced business environment, sustainable technology isn’t just a nice-to-have – it’s a strategic imperative. Behavioral r esistance : Change is hard.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content